Schaaf-Yang Syndrome News

Categories:

SYS (31) | Research (2) |

Researcher Spotlight: Dr. Rachel Gilmore and Clara Borlinghaus Advance Understanding of Schaaf-Yang Syndrome

At Heidelberg University Hospital in Germany, Dr. Rachel Gilmore and medical student Clara Borlinghaus are working together to advance research in Schaaf-Yang syndrome (SYS), a rare genetic condition linked to changes in the MAGEL2 gene.

Researcher Spotlight: Dr. Ferdinand Althammer and the Role of Oxytocin in Schaaf-Yang Syndrome

Dr. Ferdinand Althammer is a neuroscientist with a deep commitment to understanding the biology behind Schaaf-Yang syndrome (SYS) — and to ensuring that families remain at the heart of that work.

GeneSYS Initiative Spotlighted on RARECast Podcast

FPWR’s Director of Research Programs, Dr. Theresa Strong, recently joined Daniel Levine on the RARECast podcast to discuss the GeneSYS initiative—FPWR’s translational research program focused on developing a targeted therapy for Schaaf-Yang syndrome ...

Alia’s Journey: From Uncertainty to Unstoppable

Alia is our youngest of four. We moved back to Los Angeles from San Francisco while pregnant with her, full of excitement for adding another Pesce to the pond. We had no reason to expect anything out of the ordinary — until, shortly after she was bor...

Top 10 Reasons to Attend the 2026 FPWR Schaaf-Yang Syndrome Conference in Philadelphia

Join us October 9–10 in Philadelphia for the annual FPWR Family Conference, a unique gathering dedicated to families and professionals affected by Schaaf-Yang syndrome. Over two powerful days, leading researchers, clinicians, and families from around...

Celebrating Rare Disease Day: Spotlight on Three Inspiring Families

With February 28 marking Rare Disease Day, we honor the courage, joy, and resilience of families living with Schaaf-Yang Syndrome (SYS). It’s a day to raise awareness, celebrate progress, and highlight the critical need for research and support for c...
GeneSYS - The First Chapter in SYS Treatments - Program Update

GeneSYS Update: Meaningful Progress Toward a Targeted Therapy for Schaaf-Yang Syndrome

During the recent GeneSYS Update Town Hall, FPWR shared encouraging progress on the GeneSYS project, a research initiative focused on developing a targeted therapeutic approach for Schaaf-Yang syndrome (SYS). While this work is still in the early sta...

SYS Glossary of Key Terms

Understanding the science behind Schaaf-Yang Syndrome (SYS) can feel overwhelming—but you don’t need to be a scientist to make sense of it. Here’s a clear, family-friendly glossary of key terms you may encounter when learning about SYS, research, or ...

Understanding Oxytocin in Schaaf-Yang Syndrome: What Families Should Know

Interest in oxytocin as a possible treatment for Schaaf-Yang syndrome (SYS) has been growing in recent years. To help clarify what is currently known, Dr. Christian Schaaf, whose research first identified the MAGEL2 gene changes that cause SYS, share...

A Birthday Filled With Pumpkins, Love, and Hope for Lyla

When Kim Fonseca began thinking about how to celebrate her daughter Lyla’s birthday this year, she knew two things for certain: she wanted it to be simple, and she wanted it to matter. Life with Schaaf-Yang syndrome (SYS) brings intense days — therap...